Thermo Fisher Scientific Inc · NYSE:TMO
Thermo Fisher Scientific — Shareholder Meeting (May 2026)
16 slides from Thermo Fisher Scientific's shareholder meeting presentation, May 20, 2026
Slide 1: Annual Meeting of Shareholders 2026
Annual Meeting of Shareholders 2026 Marc N. Casper Chairman and Chief Executive Officer Julia L. Chen Vice President and Corporate Secretary The world leader in serving science Proprietary | May 20, 2026
Slide 2: Meeting Agenda
Annual Meeting of Shareholders Meeting Agenda • Call to Order and Instructions • Voting Matters • Questions and Answers on Voting Matters • Closing of Polls • Preliminary Voting Report • Management Presentation • Questions and Answers on General Matters • Adjournment 2 Proprietary | May 20, 2026
Slide 3: Safe Harbor Statement
Annual Meeting of Shareholders Safe Harbor Statement Various remarks that we may make about the Company’s future expectations, plans and prospects constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual resul
Slide 4: Voting Matters
Annual Meeting of Shareholders Voting Matters • Proposal 1: Election of Directors • Proposal 2: Approval of an Advisory Vote on Executive Compensation • Proposal 3: Ratification of the Selection of the Independent Auditors for 2026 4 Proprietary | May 20, 2026
Slide 5: Questions
Questions Annual Meeting of Shareholders 2026 5 Proprietary | May 20, 2026
Slide 6: Voting Matters
Annual Meeting of Shareholders Voting Matters • Proposal 1: Election of Directors • Proposal 2: Approval of an Advisory Vote on Executive Compensation • Proposal 3: Ratification of the Selection of the Independent Auditors for 2026 6 Proprietary | May 20, 2026
Slide 7: Company Overview
Company Overview Annual Meeting of Shareholders 2026 Marc N. Casper Chairman and Chief Executive Officer The world leader in serving science Proprietary | May 20, 2026
Slide 8: World leader in serving science
World leader in serving science LEADING BRANDS INDUSTRY- LEADING SCALE $45B >125,000 $1.4B revenue colleagues R&D investment • Leading innovative technologies • Exceptional commercial reach • Premier productivity partner INCREDIBLE • Deep applications expertise • Unique customer access • Continually
Slide 9: Our Mission is our purpose
Our Mission is our purpose We enable our customers to make the world healthier, cleaner and safer 9
Slide 10: Very attractive revenue profile
Very attractive revenue profile $45B Revenue Leadership in attractive end markets Very strong recurring revenue mix Unparalleled commercial engine Services & North Pharma & Consumables America Biotech 57% 84% 51% END PRODUCTS ROW REGIONS MARKETS Industrial & Applied 4% 14% Instruments Diagnostics &
Slide 11: Complementary segments with industry-leading businesses
Complementary segments with industry-leading businesses LIFE SCIENCES ANALYTICAL SPECIALTY DIAGNOSTICS LABORATORY PRODUCTS SOLUTIONS INSTRUMENTS & BIOPHARMA SERVICES Leading portfolio serving Leading analytical Leadership in specialty Enabling biopharma with bioproduction, life sciences technologies
Slide 12: Creating value for all our stakeholders
Creating value for all our stakeholders CUSTOMERS COMMUNITIES The trusted partner that Enhancing our local accelerates our customers’ communities and improving innovation and enhances the world for current and their productivity future generations COLLEAGUES SHAREHOLDERS A great place to have Outsta
Slide 13: Our PPI Business System enables outstanding execution
Our PPI Business System enables outstanding execution Quality Results World-class products and Delivers services competitive Our culture advantage and mindset Productivity Operating engages every and process colleague to efficiency Successful and cost find a better management acquisitions way every
Slide 14: Proven track record of delivering exceptional financial results
Proven track record of delivering exceptional financial results REVENUE ($B) ADJUSTED EPS FREE CASH FLOW ($B) 10% CAGR 12% CAGR 10% CAGR $44.6 $22.87 $6.3 $17.0 $2.5 $7.38 2015 2025 2015 2025 2015 2025 14
Slide 15: Key takeaways of the day
Key takeaways of the day • Incredibly well-positioned industry leader, with leading businesses that benefit from the scale and depth of our combined capabilities • We serve attractive and improving end markets, powered by strong long-term fundamentals • We actively manage the company to deliver outs
Slide 16: Questions
Questions Annual Meeting of Shareholders 2026 16 Proprietary | May 20, 2026
Thermo Fisher Scientific — Shareholder Meeting (May 2026) on 6ix